New trends in the drug therapy of localized and disseminated Mycobacterium avium complex infection

American Journal of Health-System Pharmacy

Volumn 53, Issue 21, 1996, Pages 2585-2590

  Sesin, G Paul ^a,b   Manzi, Shannon French ^c   Pacheco, Raquel ^d  

^a Clinical Services   (United States)

^b Charlton Memorial Hospital   (United States)

^c YALE NEW HAVEN CHILDREN S HOSPITAL   (United States)

^d CVS Caremark   (United States)

Author keywords

Acquired immunodeficiency syndrome; Amikacin; Aminoglycosides; Anti infective agents; Antituberculars; Azithromycin; Ciprofloxacin; Clarithromycin; Clofazimine; Combined therapy; Diagnosis; Ethambutol; HIV infections; Immunotherapy; Macrolides; Mycobacterium avium complex; Quinolones; Rifabutin; Rifampin; Interferon

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; ETHAMBUTOL; GAMMA INTERFERON; MACROLIDE; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; RIFAMPICIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBACTERIAL ACTIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOTHERAPY; MILIARY TUBERCULOSIS; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SURVIVAL TIME;

EID: 0029963513     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/53.21.2585     Document Type: Review

References (29)

1. Sullam PM, Gordin FM, Wynne BA et al. Efficacy of rifabutin in the treatment of disseminated infection due to Mycobacterium avium complex. Clin Infect Dis. 1994; 19:84-6.
2. Benson CA. Mycobacterium avium complex disease in patients with AIDS. Infect Dis Clin Pract. 1995; 1(4):1-10.
3. O'Brien RJ, Geiter LJ, Snider DE. The epidemiology of nontuberculosis mycobacterial diseases in the United States. Am Rev Respir Dis. 1987; 135:438-41.
4. Kennedy TP, Weber DJ. Nontuberculous mycobacteria: an underappreciated cause of geriatric lung disease. Am J Respir Crit Care Med. 1994; 149:1654-8.
5. Fordham von Reyn C, Maslow JIV, Barber TW et al. Persistent colonization of potable water as a source of Mycobacterium avium infection in AIDS. Lancet. 1994; 343:1137-41.
6. Montecalvo MA, Forester G, Tsang AY et al. Colonization of potable water with Mycobacterium avium complex in homes of HIV-infected patients. Lancet. 1994; 343:1639. Letter.
7. Horsburgh CR. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med. 1991; 324:1332-8.
8. Chin DP, Reingold AL, Stone EN et al. The impact of Mycobacterium avium complex and its treatment on survival of AIDS patients - a prospective study. J Infect Dis. 1994; 170:578-84.
9. Kreher M, Zurlo JJ. Treatment strategies for Mycobacterium avium complex infections. Contemp Intern Med. 1993; 5(Dec).
10. Wallace RJ. Mycobacterium avium complex lung disease and women: now an equal opportunity disease. Chest. 1994; 105:6-7. Editorial.
11. Young LS. The 10 most common questions about Mycobacterium avium complex. Infect Dis Clin Pract. 1995; 4(3):172-6.
12. Benson C, Ellner JJ. Mycobacterium avium complex infection and AIDS: advances in theory and practice. Clin Infect Dis. 1993; 17:7-20.
13. Bartlett JG, Feinberg J. Management of opportunistic infections in patients with HIV infection: update. Infect Dis Clin Pract. 1995; 4(4):267-76.
14. Sepkowitz KA, Armstrong D. Treatment of opportunistic infections in AIDS. Lancet. 1995; 346:588-9.
15. Chaisson RE, Benson CA, Duke MP et al. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. Ann Intern Med. 1994; 121:905-11.
16. Chaisson RE. Mycobacterium avium complex. PAACNOTES. 1993; Sep:374-7.
17. Berning SE, Madsen L, Iseman MD et al. Long-term safety of ofloxacin and ciprofloxacin in treatment of mycobacterial infections. Am J Respir Crit Care Med. 1995; 151:2006-9.
18. Kemper CA, Meng T-C, Nussbaum J et al. Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Ann Intern Med. 1992; 116:466-72.
19. Dautzenberg B, Marc TS, Meyohas MC et al. Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome. Arch Intern Med. 1993; 153:368-72.
20. Wallace RJ Jr, Brown BA, Griffith DE et al. Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease. Am J Respir Crit Care Med. 1994; 149:1335-41.
21. Davey RT Jr. Mycobacterial disease in HIV-1 infection: recent therapeutic advances. In: Lane HC, moderator. Recent advances in the management of AIDS-related opportunistic infections. Ann Intern Med. 1994; 120:945-55.
22. Holland S, Eisenstein EM, Kuhns DB et al. Treatment of refractory disseminated nontuberculosis mycobacterial infection with interferon gamma. N Engl J Med. 1994; 330:1348-55.
23. McIntyre K, Torres R, Barr M et al. Open study of clarithromycin for primary prevention of symptomatic Mycobacterium avium complex (MAC) disease. Paper presented at Sexually Transmitted Diseases World Congress. Berlin, Germany; 1993 Jun 7-11.
24. Pierce M and the Clarithromycin MAC Prophylaxis Treatment Group. A placebo controlled trial of Clarithromycin prophylaxis against MAC infection in AIDS patients. Paper presented at Interscience Conference on Antimicrobial Agents and Chemotherapy. Orlando, FL; 1994.
25. Peters DH, Clissold SP. Clarithromycin: a review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential. Drugs. 1992; 44:117-64.
26. Masur H and the Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium complex. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. N Engl J Med. 1993; 329:898-904.
27. Red book. Doherty MS, ed. Montvale, NJ: Medical Economics; 1995.
28. Havlir D, Torriani F, Dube M. Uveitis associated with rifabutin prophylaxis. Ann Intern Med. 1994; 121:510-2.
29. Centers for Disease Control and Prevention. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with HIV: a summary. MMWR. 1995; 44(RR-8):1-33.